Review



hiscreen mabselecttm prisma  (Cytiva Europe)


Bioz Verified Symbol Cytiva Europe is a verified supplier
Bioz Manufacturer Symbol Cytiva Europe manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Cytiva Europe hiscreen mabselecttm prisma
    Fig. 1. Dynamic binding capacity (DBC) at 10% breakthrough. A) Comparison between MabSelect <t>PrismA</t> (dashed line) and Fibro PrismA (solid line) with log residence time. The residence time for Fibro™ PrismA was < 1 min and for MabSelect™ PrismA 4–5 min. B) Fibro PrismA DBC against residence time fitted by a two- parameter power function (dashed line). IgG1(•); IgG4–1 (∎); IgG4–2 (▴); IgG4–3(▾) and trivalent Fc (◆).
    Hiscreen Mabselecttm Prisma, supplied by Cytiva Europe, used in various techniques. Bioz Stars score: 93/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hiscreen+mabselecttm+prisma/HiScreen+MabSelect+PrismA/10__1016_slash_j__bej__2023__109141-55-3-28
    Average 93 stars, based on 2 article reviews
    hiscreen mabselecttm prisma - by Bioz Stars, 2026-08
    93/100 stars

    Images

    1) Product Images from "Economic optimization of antibody capture through Protein A affinity nanofiber chromatography"

    Article Title: Economic optimization of antibody capture through Protein A affinity nanofiber chromatography

    Journal: Biochemical Engineering Journal

    doi: 10.1016/j.bej.2023.109141

    Fig. 1. Dynamic binding capacity (DBC) at 10% breakthrough. A) Comparison between MabSelect PrismA (dashed line) and Fibro PrismA (solid line) with log residence time. The residence time for Fibro™ PrismA was < 1 min and for MabSelect™ PrismA 4–5 min. B) Fibro PrismA DBC against residence time fitted by a two- parameter power function (dashed line). IgG1(•); IgG4–1 (∎); IgG4–2 (▴); IgG4–3(▾) and trivalent Fc (◆).
    Figure Legend Snippet: Fig. 1. Dynamic binding capacity (DBC) at 10% breakthrough. A) Comparison between MabSelect PrismA (dashed line) and Fibro PrismA (solid line) with log residence time. The residence time for Fibro™ PrismA was < 1 min and for MabSelect™ PrismA 4–5 min. B) Fibro PrismA DBC against residence time fitted by a two- parameter power function (dashed line). IgG1(•); IgG4–1 (∎); IgG4–2 (▴); IgG4–3(▾) and trivalent Fc (◆).

    Techniques Used: Binding Assay, Comparison

    Fig. 2. Binding signal between different concentrations of proteins and PrismA ligands. A) Illustration of the SPR technique to determine static binding capacity. B) Experimental data and the fit to a Langmuir isotherm for binding signal against protein concentration. C) Error margins of parameter Qmax for each mAb. D) Error margins of parameter keq for each mAb.
    Figure Legend Snippet: Fig. 2. Binding signal between different concentrations of proteins and PrismA ligands. A) Illustration of the SPR technique to determine static binding capacity. B) Experimental data and the fit to a Langmuir isotherm for binding signal against protein concentration. C) Error margins of parameter Qmax for each mAb. D) Error margins of parameter keq for each mAb.

    Techniques Used: Binding Assay, Protein Concentration

    Fig. 4. Protein impurity clearance by MabSelect PrismA at 0.25 CV min-1 (∎) and Fibro PrismA at 40 MV min-1(•) as a function of the load density. Aggregates reduction is shown on the left hand side for IgG1, IgG4–3 and Trivalent Fc; while host cell protein (HCP) reduction is on the right hand side for the same proteins.
    Figure Legend Snippet: Fig. 4. Protein impurity clearance by MabSelect PrismA at 0.25 CV min-1 (∎) and Fibro PrismA at 40 MV min-1(•) as a function of the load density. Aggregates reduction is shown on the left hand side for IgG1, IgG4–3 and Trivalent Fc; while host cell protein (HCP) reduction is on the right hand side for the same proteins.

    Techniques Used:

    Fig. 5. Comparison of chromatograms for different elution volumes (10 MV and 15 MV) with HiTrap (0.4 mL) and HiScreen (3.75 mL) Fibro™ PrismA devices using IgG4–3 as the model. A) Whole chromatograms starting from sample loading; B) Elution profile. HiTrap Fibro PrismA and HiScreen Fibro PrismA were operated using ¨Akta Pure 25 and ¨Akta Pure 150, respectively.
    Figure Legend Snippet: Fig. 5. Comparison of chromatograms for different elution volumes (10 MV and 15 MV) with HiTrap (0.4 mL) and HiScreen (3.75 mL) Fibro™ PrismA devices using IgG4–3 as the model. A) Whole chromatograms starting from sample loading; B) Elution profile. HiTrap Fibro PrismA and HiScreen Fibro PrismA were operated using ¨Akta Pure 25 and ¨Akta Pure 150, respectively.

    Techniques Used: Comparison

    Fig. 6. Overlay of 200 cycles of IgG4–3 capture on Fibro PrismA for: A) Chromatograms; B) Delta pressure drop; C) Eluate peak width at half height; D) Peak height; E) Eluate volume; and F) Protein recovery.
    Figure Legend Snippet: Fig. 6. Overlay of 200 cycles of IgG4–3 capture on Fibro PrismA for: A) Chromatograms; B) Delta pressure drop; C) Eluate peak width at half height; D) Peak height; E) Eluate volume; and F) Protein recovery.

    Techniques Used:

    Fig. 7. Eluate quality over 200 cycles of IgG4–3 capture on Fibro PrismA. A) Aggregate reduction; B) Log HCP reduction; C) Intensity Average Particle size; and D) Protein A ligand leakage level.
    Figure Legend Snippet: Fig. 7. Eluate quality over 200 cycles of IgG4–3 capture on Fibro PrismA. A) Aggregate reduction; B) Log HCP reduction; C) Intensity Average Particle size; and D) Protein A ligand leakage level.

    Techniques Used:

    Fig. 9. Cost comparison between MabSelect PrismA and Fibro PrismA at manufacturing scale (2000 L). A) Total cost comparison for a single batch. Cost per gram mAb processed for up to 20 harvests at a manufacturing scale for B) A new membrane device is replaced every harvest; and C) The membrane device is replaced every 4 harvests (200 cycles).
    Figure Legend Snippet: Fig. 9. Cost comparison between MabSelect PrismA and Fibro PrismA at manufacturing scale (2000 L). A) Total cost comparison for a single batch. Cost per gram mAb processed for up to 20 harvests at a manufacturing scale for B) A new membrane device is replaced every harvest; and C) The membrane device is replaced every 4 harvests (200 cycles).

    Techniques Used: Comparison, Membrane

    Fig. 8. Helium ion microscopy analysis of Fibro PrismA before and after 200 cycles. A), B) Unused Fibro PrismA. C), D) Outlet region of the Fibro PrismA after 200 cycles at two different resolutions. The red circles showed polymer beads of fibers resulting from the electrospinning process.
    Figure Legend Snippet: Fig. 8. Helium ion microscopy analysis of Fibro PrismA before and after 200 cycles. A), B) Unused Fibro PrismA. C), D) Outlet region of the Fibro PrismA after 200 cycles at two different resolutions. The red circles showed polymer beads of fibers resulting from the electrospinning process.

    Techniques Used: Microscopy, Polymer

    Fig. 10. Cost comparison between MabSelect PrismA and Fibro PrismA at A) Pilot scale (200 L) and B) Clinical Scale (500 L).
    Figure Legend Snippet: Fig. 10. Cost comparison between MabSelect PrismA and Fibro PrismA at A) Pilot scale (200 L) and B) Clinical Scale (500 L).

    Techniques Used: Comparison



    Similar Products

    hiscreen mabselecttm prisma  (Cytiva Europe)
    93
    Cytiva Europe hiscreen mabselecttm prisma
    Fig. 1. Dynamic binding capacity (DBC) at 10% breakthrough. A) Comparison between MabSelect <t>PrismA</t> (dashed line) and Fibro PrismA (solid line) with log residence time. The residence time for Fibro™ PrismA was < 1 min and for MabSelect™ PrismA 4–5 min. B) Fibro PrismA DBC against residence time fitted by a two- parameter power function (dashed line). IgG1(•); IgG4–1 (∎); IgG4–2 (▴); IgG4–3(▾) and trivalent Fc (◆).
    Hiscreen Mabselecttm Prisma, supplied by Cytiva Europe, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hiscreen+mabselecttm+prisma/HiScreen+MabSelect+PrismA/10__1016_slash_j__bej__2023__109141-55-3-28
    Average 93 stars, based on 1 article reviews
    hiscreen mabselecttm prisma - by Bioz Stars, 2026-08
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    Fig. 1. Dynamic binding capacity (DBC) at 10% breakthrough. A) Comparison between MabSelect PrismA (dashed line) and Fibro PrismA (solid line) with log residence time. The residence time for Fibro™ PrismA was < 1 min and for MabSelect™ PrismA 4–5 min. B) Fibro PrismA DBC against residence time fitted by a two- parameter power function (dashed line). IgG1(•); IgG4–1 (∎); IgG4–2 (▴); IgG4–3(▾) and trivalent Fc (◆).

    Journal: Biochemical Engineering Journal

    Article Title: Economic optimization of antibody capture through Protein A affinity nanofiber chromatography

    doi: 10.1016/j.bej.2023.109141

    Figure Lengend Snippet: Fig. 1. Dynamic binding capacity (DBC) at 10% breakthrough. A) Comparison between MabSelect PrismA (dashed line) and Fibro PrismA (solid line) with log residence time. The residence time for Fibro™ PrismA was < 1 min and for MabSelect™ PrismA 4–5 min. B) Fibro PrismA DBC against residence time fitted by a two- parameter power function (dashed line). IgG1(•); IgG4–1 (∎); IgG4–2 (▴); IgG4–3(▾) and trivalent Fc (◆).

    Article Snippet: The resin column, HiScreen MabSelectTM PrismA (4.7 mL) with a 15–40 nm pore diameter, 10 cm bed height and 40 m2 g-1 surface area, was also purchased from Cytiva (Sweden).

    Techniques: Binding Assay, Comparison

    Fig. 2. Binding signal between different concentrations of proteins and PrismA ligands. A) Illustration of the SPR technique to determine static binding capacity. B) Experimental data and the fit to a Langmuir isotherm for binding signal against protein concentration. C) Error margins of parameter Qmax for each mAb. D) Error margins of parameter keq for each mAb.

    Journal: Biochemical Engineering Journal

    Article Title: Economic optimization of antibody capture through Protein A affinity nanofiber chromatography

    doi: 10.1016/j.bej.2023.109141

    Figure Lengend Snippet: Fig. 2. Binding signal between different concentrations of proteins and PrismA ligands. A) Illustration of the SPR technique to determine static binding capacity. B) Experimental data and the fit to a Langmuir isotherm for binding signal against protein concentration. C) Error margins of parameter Qmax for each mAb. D) Error margins of parameter keq for each mAb.

    Article Snippet: The resin column, HiScreen MabSelectTM PrismA (4.7 mL) with a 15–40 nm pore diameter, 10 cm bed height and 40 m2 g-1 surface area, was also purchased from Cytiva (Sweden).

    Techniques: Binding Assay, Protein Concentration

    Fig. 4. Protein impurity clearance by MabSelect PrismA at 0.25 CV min-1 (∎) and Fibro PrismA at 40 MV min-1(•) as a function of the load density. Aggregates reduction is shown on the left hand side for IgG1, IgG4–3 and Trivalent Fc; while host cell protein (HCP) reduction is on the right hand side for the same proteins.

    Journal: Biochemical Engineering Journal

    Article Title: Economic optimization of antibody capture through Protein A affinity nanofiber chromatography

    doi: 10.1016/j.bej.2023.109141

    Figure Lengend Snippet: Fig. 4. Protein impurity clearance by MabSelect PrismA at 0.25 CV min-1 (∎) and Fibro PrismA at 40 MV min-1(•) as a function of the load density. Aggregates reduction is shown on the left hand side for IgG1, IgG4–3 and Trivalent Fc; while host cell protein (HCP) reduction is on the right hand side for the same proteins.

    Article Snippet: The resin column, HiScreen MabSelectTM PrismA (4.7 mL) with a 15–40 nm pore diameter, 10 cm bed height and 40 m2 g-1 surface area, was also purchased from Cytiva (Sweden).

    Techniques:

    Fig. 5. Comparison of chromatograms for different elution volumes (10 MV and 15 MV) with HiTrap (0.4 mL) and HiScreen (3.75 mL) Fibro™ PrismA devices using IgG4–3 as the model. A) Whole chromatograms starting from sample loading; B) Elution profile. HiTrap Fibro PrismA and HiScreen Fibro PrismA were operated using ¨Akta Pure 25 and ¨Akta Pure 150, respectively.

    Journal: Biochemical Engineering Journal

    Article Title: Economic optimization of antibody capture through Protein A affinity nanofiber chromatography

    doi: 10.1016/j.bej.2023.109141

    Figure Lengend Snippet: Fig. 5. Comparison of chromatograms for different elution volumes (10 MV and 15 MV) with HiTrap (0.4 mL) and HiScreen (3.75 mL) Fibro™ PrismA devices using IgG4–3 as the model. A) Whole chromatograms starting from sample loading; B) Elution profile. HiTrap Fibro PrismA and HiScreen Fibro PrismA were operated using ¨Akta Pure 25 and ¨Akta Pure 150, respectively.

    Article Snippet: The resin column, HiScreen MabSelectTM PrismA (4.7 mL) with a 15–40 nm pore diameter, 10 cm bed height and 40 m2 g-1 surface area, was also purchased from Cytiva (Sweden).

    Techniques: Comparison

    Fig. 6. Overlay of 200 cycles of IgG4–3 capture on Fibro PrismA for: A) Chromatograms; B) Delta pressure drop; C) Eluate peak width at half height; D) Peak height; E) Eluate volume; and F) Protein recovery.

    Journal: Biochemical Engineering Journal

    Article Title: Economic optimization of antibody capture through Protein A affinity nanofiber chromatography

    doi: 10.1016/j.bej.2023.109141

    Figure Lengend Snippet: Fig. 6. Overlay of 200 cycles of IgG4–3 capture on Fibro PrismA for: A) Chromatograms; B) Delta pressure drop; C) Eluate peak width at half height; D) Peak height; E) Eluate volume; and F) Protein recovery.

    Article Snippet: The resin column, HiScreen MabSelectTM PrismA (4.7 mL) with a 15–40 nm pore diameter, 10 cm bed height and 40 m2 g-1 surface area, was also purchased from Cytiva (Sweden).

    Techniques:

    Fig. 7. Eluate quality over 200 cycles of IgG4–3 capture on Fibro PrismA. A) Aggregate reduction; B) Log HCP reduction; C) Intensity Average Particle size; and D) Protein A ligand leakage level.

    Journal: Biochemical Engineering Journal

    Article Title: Economic optimization of antibody capture through Protein A affinity nanofiber chromatography

    doi: 10.1016/j.bej.2023.109141

    Figure Lengend Snippet: Fig. 7. Eluate quality over 200 cycles of IgG4–3 capture on Fibro PrismA. A) Aggregate reduction; B) Log HCP reduction; C) Intensity Average Particle size; and D) Protein A ligand leakage level.

    Article Snippet: The resin column, HiScreen MabSelectTM PrismA (4.7 mL) with a 15–40 nm pore diameter, 10 cm bed height and 40 m2 g-1 surface area, was also purchased from Cytiva (Sweden).

    Techniques:

    Fig. 9. Cost comparison between MabSelect PrismA and Fibro PrismA at manufacturing scale (2000 L). A) Total cost comparison for a single batch. Cost per gram mAb processed for up to 20 harvests at a manufacturing scale for B) A new membrane device is replaced every harvest; and C) The membrane device is replaced every 4 harvests (200 cycles).

    Journal: Biochemical Engineering Journal

    Article Title: Economic optimization of antibody capture through Protein A affinity nanofiber chromatography

    doi: 10.1016/j.bej.2023.109141

    Figure Lengend Snippet: Fig. 9. Cost comparison between MabSelect PrismA and Fibro PrismA at manufacturing scale (2000 L). A) Total cost comparison for a single batch. Cost per gram mAb processed for up to 20 harvests at a manufacturing scale for B) A new membrane device is replaced every harvest; and C) The membrane device is replaced every 4 harvests (200 cycles).

    Article Snippet: The resin column, HiScreen MabSelectTM PrismA (4.7 mL) with a 15–40 nm pore diameter, 10 cm bed height and 40 m2 g-1 surface area, was also purchased from Cytiva (Sweden).

    Techniques: Comparison, Membrane

    Fig. 8. Helium ion microscopy analysis of Fibro PrismA before and after 200 cycles. A), B) Unused Fibro PrismA. C), D) Outlet region of the Fibro PrismA after 200 cycles at two different resolutions. The red circles showed polymer beads of fibers resulting from the electrospinning process.

    Journal: Biochemical Engineering Journal

    Article Title: Economic optimization of antibody capture through Protein A affinity nanofiber chromatography

    doi: 10.1016/j.bej.2023.109141

    Figure Lengend Snippet: Fig. 8. Helium ion microscopy analysis of Fibro PrismA before and after 200 cycles. A), B) Unused Fibro PrismA. C), D) Outlet region of the Fibro PrismA after 200 cycles at two different resolutions. The red circles showed polymer beads of fibers resulting from the electrospinning process.

    Article Snippet: The resin column, HiScreen MabSelectTM PrismA (4.7 mL) with a 15–40 nm pore diameter, 10 cm bed height and 40 m2 g-1 surface area, was also purchased from Cytiva (Sweden).

    Techniques: Microscopy, Polymer

    Fig. 10. Cost comparison between MabSelect PrismA and Fibro PrismA at A) Pilot scale (200 L) and B) Clinical Scale (500 L).

    Journal: Biochemical Engineering Journal

    Article Title: Economic optimization of antibody capture through Protein A affinity nanofiber chromatography

    doi: 10.1016/j.bej.2023.109141

    Figure Lengend Snippet: Fig. 10. Cost comparison between MabSelect PrismA and Fibro PrismA at A) Pilot scale (200 L) and B) Clinical Scale (500 L).

    Article Snippet: The resin column, HiScreen MabSelectTM PrismA (4.7 mL) with a 15–40 nm pore diameter, 10 cm bed height and 40 m2 g-1 surface area, was also purchased from Cytiva (Sweden).

    Techniques: Comparison